The 7-OH category shifted in early July 2026, and most of the search results on this topic are either sales pages pushing alternate alkaloids or recovery-site warnings. This page does something simpler: it maps what is inside the DEA threshold versus outside it, using only the figures the agency published, so you can see which product classes are affected and which are not.
What exactly did the DEA do in July 2026?
The DEA filed a Notice of Intent on July 1, 2026 to temporarily place concentrated 7-hydroxymitragynine into Schedule I of the Controlled Substances Act. The notice was published in the Federal Register on July 6, 2026, which starts a 30-day waiting period before any temporary scheduling can take effect. Based on that publication date, the earliest effective date is roughly August 5, 2026. This is a factual timeline, not a prediction — the agency can act on or after that date, and dates can move.
What is actually covered by the scheduling action?
The action is written around a concentration threshold, not around kratom as a whole. Two figures define it:
- More than 1 mg of 7-OH per product, or
- More than 0.05% 7-OH by dry weight
It also names three synthetic derivatives specifically: mitragynine pseudoindoxyl (MP), MGM-15, and MGM-16. Those are lab-made compounds, distinct from what occurs naturally in the leaf.
What is NOT covered?
Per the notice as published, natural kratom leaf that sits below the 1 mg / 0.05% threshold is not part of the scheduling action. Mitragynine — the primary naturally occurring alkaloid in the leaf — is not itself the target here; the action is aimed at concentrated and enhanced 7-OH and the three synthetics above. This is the distinction that matters when people ask about "legal alternatives."
In vs. out: a quick reference
| Product class | Status under the July 2026 action | What to check |
|---|---|---|
| Concentrated / enhanced 7-OH (over 1 mg or over 0.05% by dry weight) | Named in the scheduling action | Label serving size and COA 7-OH content |
| Synthetic derivatives: MP, MGM-15, MGM-16 | Named in the scheduling action | Ingredient list; these are lab-made, not leaf-derived |
| Natural kratom leaf below the threshold | Not named in the scheduling action | COA showing 7-OH under 0.05% by dry weight; your state's law |
| Mitragynine-forward leaf products | Not named in the scheduling action | COA and label; state KCPA rules |
How do I tell which category a product falls into?
Two documents settle it: the product label and the Certificate of Analysis (COA). The label states the serving size and what the product is; the COA reports the measured 7-OH content, which is what the threshold is written against. We publish COAs for our catalog on the lab results page so you can read the numbers yourself rather than take a claim on faith. We do not offer dosing guidance — the label states serving size per label, and that is the only strength framing we give.
Does state law still matter?
Yes. Beyond the federal action, individual states set their own rules, many through the Kratom Consumer Protection Act (KCPA). State-law variance means a product class that is not federally scheduled can still be restricted where you live. Favor'd ALKz does not ship to restricted states, and orders are 21+ only. Always confirm your own state's current status before buying.
So which products fall outside the threshold?
The practical takeaway: the product classes that fall outside the named threshold are natural leaf-based options — subject to your state's law and to whatever the DEA finalizes. If you're browsing, our powder collection and tablet collection each list serving size per label and link to their COAs. We are not claiming any product will remain legal indefinitely; we are pointing you to the label and COA so you can match a product to the threshold figures above and decide for yourself.
Frequently asked questions
Is all 7-OH becoming illegal in 2026?
No. The July 2026 action is written around concentrated 7-OH — over 1 mg per product or over 0.05% by dry weight — plus three named synthetics (MP, MGM-15, MGM-16). Natural leaf below that threshold is not named in the action.
When would the scheduling take effect?
The notice published in the Federal Register on July 6, 2026, triggering a 30-day waiting period. That puts the earliest possible effective date at roughly August 5, 2026. Temporary scheduling can occur on or after that point.
What are MP, MGM-15, and MGM-16?
They are synthetic derivatives — lab-made compounds named specifically in the scheduling action, separate from the naturally occurring alkaloids in kratom leaf.
How do I verify a product's 7-OH content?
Check the Certificate of Analysis. Every product we sell links to its COA on our lab results page, which reports measured 7-OH content — the figure the DEA threshold is written against.
Will my state allow it?
That depends on your state. Many states regulate through the Kratom Consumer Protection Act, and rules vary. We do not ship to restricted states, and all orders are 21+.
These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease. For adults 21+.
